Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Faes Farma's Enterprise Value is €1,031.8 Mil.
Faes Farma's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €78.5 Mil. Therefore, Faes Farma's EV-to-EBIT ratio for today is 13.14.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Faes Farma's Enterprise Value is €1,031.8 Mil.
Faes Farma's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €83.6 Mil. Therefore, Faes Farma's EV-to-EBITDA ratio for today is 12.35.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Faes Farma's Enterprise Value is €1,031.8 Mil.
Faes Farma's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €273.7 Mil. Therefore, Faes Farma's EV-to-Revenue ratio for today is 3.77.
Faes Farma Enterprise Value Historical Data
The historical data trend for Faes Farma's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Faes Farma's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Faes Farma's Enterprise Value falls into.
Faes Farma Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Faes Farma's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma (XMAD:FAE) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Faes Farma's current Enterprise Value is €1,031.8 Mil.
Faes Farma's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €78.5 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Faes Farma's current Enterprise Value is €1,031.8 Mil.
Faes Farma's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €83.6 Mil.
Faes Farma's current Enterprise Value is €1,031.8 Mil.
Faes Farma's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €273.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma Enterprise Value Related Terms
Thank you for viewing the detailed overview of Faes Farma's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XMAD:FAE has been successfully added to your 